Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Over a median follow-up time of 21.4 years, 603 participants developed cardiovascular disease, 362 developed diabetes, and 843 participants passed away
Common side effects include nausea, vomiting, and gastrointestinal discomfort
Liraglutide (Saxenda) was one of the earlier forms of longer-lasting GLP-1s and reduces HbA1c (average blood glucose) levels by around 1.3% on average and fasting plasma glucose by 2 mmol/L
Aroda reports institutional contracts from Amgen, Applied Therapeutics, AstraZeneca, Biomea, Boehringer Ingelheim, Corcept, Eli Lilly, Fractyl, Kailera, Novo Nordisk, Pfizer, Recordati, Rhythm and Servier, as well as consulting fees from Baim Institute for Clinical Research, Mediflix, Sanofi, and Roche
US$ 29.79
US$ 22.45
US$ 25.43
US$ 23.09
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
